Alerts
PDF
Other content recommended for you
- Prevalence of methylphenidate use by Master of Medicine students at a South African university
- Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials
- Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
- Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile
- Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial
- Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater
- Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
- Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design